About Subhasree Kar
Subhasree’s keen interest in financial instruments led her to pursue a career as an investment analyst. After earning a Master’s degree in Economics, she gained knowledge of equity research and portfolio management at Finlatics.
She uses her knowledge as a fundamental analyst to help investors make informed decisions in regards to their investment portfolios.
Recent Articles By Subhasree Kar
3 Chemical Stocks to Sell Before the End of 2022
Risks around lower consumption, supply chain constraints, and inflationary pressures are expected to limit the chemical industry’s growth in the near term. Considering the headwinds, we think it might be best to steer clear of chemical stocks, Lightwave Logic (LWLG), Gevo (GEVO), and Loop Industries (LOOP), given their weak fundamentals. Read on...
2 Retail Stocks to Buy in October and 2 to Sell Short
Retail sales rose last month, with consumers showing resilience. However, the persistently high inflation and growing recession concerns are prompting consumers to cut back on discretionary spending. While investors looking for retail investments could consider buying Dillard’s (DDS) and Movado (MOV), we think Gap (GPS) and RealReal (REAL) might be best sold short, given their weak fundamentals. Read on...
Should Investors Be Excited About Tenaris’ Acquisition?
Luxembourg-based steel manufacturer Tenaris (TS) recently announced its agreement to acquire the U.S. seamless steel pipe producer Benteler Steel & Tube Manufacturing Corp, seeking to expand its manufacturing capabilities in the U.S. market. But is the company poised to benefit from this deal, and should investors keep this stock on their radar? Read on to find out…
This Biotech Stock Looks Like a Prime Growth Play
Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail…
Pinterest Picked up a New CEO - Buy, Sell, Hold?
Social media company Pinterest (PINS) recently appointed online commerce expert Bill Ready as its Chief Executive Officer. The company has been prioritizing e-commerce in recent years, and this move is expected to help its commerce business gain momentum. However, considering the challenging macro environment, should you Buy, Sell or Hold the stock now? Let’s discuss this in detail…
Is 2U Stock a Buy Under $10?
The shares of the education technology company 2U (TWOU) plunged in price after Piper Sandler analysts downgraded the stock. TWOU closed the last trading session at less than $10. However, considering the company’s significant operational prospects with its EdX acquisition, is the stock a buy now? Keep reading to learn our view.
Down 35% in 2022, is T. Rowe Price Group Now a Buy?
Investment management company T. Rowe Price Group (TROW) has been under pressure, with declining assets under management (AUM) amid rising inflation and the war in Ukraine. Its stock has slumped 35% in price this year. Also, considering the Fed’s tightening monetary policies, is TROW a buy now? Keep reading to learn what we think.
Meta Materials: Buy, Sell, or Hold?
The Canada-based functional materials and nanocomposite products developer Meta Materials (MMAT) has achieved strong topline growth in its most recent quarter, with its revenues increasing a whopping 399% year-over-year. Furthermore, MMAT recently announced its first U.S. patent granted for a non-invasive glucose sensing system, which has propelled the stock higher over the past month. However, with the company’s bottom line still in the red, will the stock’s price gains be sustained? Keep reading to learn our view.
Is Macerich a Good REIT to Own?
Real estate investment trust (REIT) Macerich’s (MAC) has been ramping up its efforts to move past pandemic disruptions and reported significant improvement in its last quarter, with robust leasing demand and tenant sales. However, MAC’s shares have plunged more than 30% in price this year. And considering bearish analysts’ sentiments around the stock, the question is, is MAC a buy now? Keep reading to learn our view.